In line with the celebration of Rare Disease Week and the 7th year celebration of the signing of the Rare Disease Act of 2016, the Stratbase ADR Institute, in partnership with PSOD and UHCWatch, organized another dialogue entitled, “Sustaining Gains and Balancing Priorities: Implementation of Rare Disease Act for 2023”, to continue the discussion on plans that will benefit the RD patients.
The discussion aimed to provide a venue for key decision makers and stakeholders to continue the previous discussions that will further institutionalize the government’s support to rare disease patients, which is aligned with the implementation of the Rare Disease Law and in accordance with the achievement of the objectives of the IRDMSP 2022-2026.
Continue Reading